Related Experiment Video
Updated: Feb 5, 2026
04:59
Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
1.6K
Smokers Display Reduced Glucocorticoid Sensitivity Prior to Symptomatic Chronic Disease Development.
J M Bennett1,2, J S Marino3, B Peck3
1Department of Psychological Science, UNC Charlotte, NC, USA.
Summary
Smokers show reduced glucocorticoid sensitivity and inflammatory response before disease onset. This suggests smoking impairs the body's anti-inflammatory defenses, increasing chronic disease risk.
Area of Science:
- Immunology
- Pharmacology
- Chronic disease research
Background:
- Chronic stress is a major contributor to disease and mortality.
- Tobacco use elevates the risk of chronic diseases and premature death.
- Smokers may develop glucocorticoid insensitivity, impairing anti-inflammatory responses.
Purpose of the Study:
- To investigate glucocorticoid sensitivity in healthy smokers versus never-smokers.
- To compare immune responses between smokers and a matched control group.
Main Methods:
- Examined 24 healthy smokers and 24 matched never-smokers.
- Collected blood samples and psychosocial data.
- Analyzed differences in glucocorticoid sensitivity using ANCOVA and linear mixed models.
Main Results:
- Smokers' peripheral blood mononuclear cells (PBMCs) showed reduced glucocorticoid sensitivity.
- Smokers exhibited a diminished inflammatory response to lipopolysaccharide compared to never-smokers.
- Findings were consistent across different statistical analyses.
Conclusions:
- Cigarette smoking acts as a chronic stressor, potentially causing early physiological wear.
- Impaired glucocorticoid sensitivity in smokers may precede clinical disease development.
- Further research on PBMCs and larger populations is warranted.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
510
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
510
01:25Chronic Kidney Disease I: Introduction
733
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
733
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K